Study of the Mitomic Endometriosis Test (MET) for Endometriosis Diagnosis
This study is looking at a new blood test called the Mitomic Endometriosis Test (MET) to see how well it can diagnose endometriosis. Endometriosis is a condition where tissue similar to the lining of the uterus grows outside the uterus. You may be able to join if you are a female between menarche (first period) and menopause, have symptoms of endometriosis, and are scheduled for your first laparoscopy (a surgical procedure to look inside the abdomen) to diagnose endometriosis. The study will compare the results of the MET blood test to the diagnosis made during your laparoscopy. The goal is to see if the MET can accurately detect endometriosis. This study aims to enroll 1000 participants.
- Study design
- This is an observational study, meaning researchers will observe participants without assigning treatments. It aims to enroll 1000 women.
- What's involved
- You will complete a questionnaire about your endometriosis symptoms and provide a blood sample before your surgical procedure. This blood sample will be sent for testing.
- Compensation
- Not stated in the trial record.
- Follow-up
- The presence or absence of endometriosis will be measured for up to 5 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Mitochondrial DNA Deletions in Plasma as a Diagnostic Aid for Females Presenting With Symptoms of Endometriosis
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Stephen A Varvel, Ph.D. · PRINCIPAL_INVESTIGATOR · Pearsanta, Inc
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Presence or absence of endometriosisup to 5 years
Presence or absence of endometriosis as determined by standard-of-care diagnostic laparoscopy